These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28288659)

  • 21. Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms.
    Nguyen TL; Aung YK; Evans CF; Yoon-Ho C; Jenkins MA; Sung J; Hopper JL; Song YM
    Breast Cancer Res; 2015 Nov; 17():142. PubMed ID: 26581435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer Risk Associations with Digital Mammographic Density by Pixel Brightness Threshold and Mammographic System.
    Nguyen TL; Choi YH; Aung YK; Evans CF; Trinh NH; Li S; Dite GS; Kim MS; Brennan PC; Jenkins MA; Sung J; Song YM; Hopper JL
    Radiology; 2018 Feb; 286(2):433-442. PubMed ID: 29040039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early life socioeconomic environment and mammographic breast density.
    Tehranifar P; Cohn BA; Flom JD; Protacio A; Cirillo P; Lumey LH; Michels KB; Terry MB
    BMC Cancer; 2017 Jan; 17(1):41. PubMed ID: 28068940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk.
    Nguyen TL; Aung YK; Evans CF; Dite GS; Stone J; MacInnis RJ; Dowty JG; Bickerstaffe A; Aujard K; Rommens JM; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Apicella C; Hopper JL
    Int J Epidemiol; 2017 Apr; 46(2):652-661. PubMed ID: 28338721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [It is time for individual breast cancer prevention].
    Hall P; Hammarström M; Hellgren R
    Lakartidningen; 2021 Sep; 118():. PubMed ID: 34498240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Density of Mammography is Correlated with Reproductive Risk Factors Regardless of Menopausal Status: A Cross-Sectional Study of the Korean National Screening Program.
    Lee JS; Oh M
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1011-1018. PubMed ID: 32334463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
    PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of statin use on volumetric mammographic density: results from the KARMA study.
    Skarping I; Brand JS; Hall P; Borgquist S
    BMC Cancer; 2015 May; 15():435. PubMed ID: 26016855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a Four-View Mammographic Image Feature Based Fusion Model to Predict Near-Term Breast Cancer Risk.
    Tan M; Pu J; Cheng S; Liu H; Zheng B
    Ann Biomed Eng; 2015 Oct; 43(10):2416-28. PubMed ID: 25851469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal trends in mammographic percent density and breast cancer risk.
    Vachon CM; Pankratz VS; Scott CG; Maloney SD; Ghosh K; Brandt KR; Milanese T; Carston MJ; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):921-8. PubMed ID: 17507617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program.
    Jiang H; Walter SD; Brown P; Raina P; Chiarelli AM
    Breast; 2019 Feb; 43():105-112. PubMed ID: 30544057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
    Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
    Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With False-Positive Recalls in Mammography Screening.
    Mao X; He W; Humphreys K; Eriksson M; Holowko N; Strand F; Hall P; Czene K
    J Natl Compr Canc Netw; 2023 Feb; 21(2):143-152.e4. PubMed ID: 36791753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.